Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Global Health ; 17(1): 18, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33522937

ABSTRACT

BACKGROUND: The success of the Sustainable Development Goals (SDGs) is predicated on multisectoral collaboration (MSC), and the COVID-19 pandemic makes it more urgent to learn how this can be done better. Complex challenges facing countries, such as COVID-19, cut across health, education, environment, financial and other sectors. Addressing these challenges requires the range of responsible sectors and intersecting services - across health, education, social and financial protection, economic development, law enforcement, among others - transform the way they work together towards shared goals. While the necessity of MSC is recognized, research is needed to understand how sectors collaborate, inform how to do so more efficiently, effectively and equitably, and ascertain similarities and differences across contexts. To answer these questions and inform practice, research to strengthen the evidence-base on MSC is critical. METHODS: This paper draws on a 12-country study series on MSC for health and sustainable development, in the context of the health and rights of women, children and adolescents. It is written by core members of the research coordination and country teams. Issues were analyzed during the study period through 'real-time' discussions and structured reporting, as well as through literature reviews and retrospective feedback and analysis at the end of the study. RESULTS: We identify four considerations that are unique to MSC research which will be of interest to other researchers, in the context of COVID-19 and beyond: 1) use theoretical frameworks to frame research questions as relevant to all sectors and to facilitate theoretical generalizability and evolution; 2) specifically incorporate sectoral analysis into MSC research methods; 3) develop a core set of research questions, using mixed methods and contextual adaptations as needed, with agreement on criteria for research rigor; and 4) identify shared indicators of success and failure across sectors to assess MSCs. CONCLUSION: In responding to COVID-19 it is evident that effective MSC is an urgent priority. It enables partners from diverse sectors to effectively convene to do more together than alone. Our findings have practical relevance for achieving this objective and contribute to the growing literature on partnerships and collaboration. We must seize the opportunity here to identify remaining knowledge gaps on how diverse sectors can work together efficiently and effectively in different settings to accelerate progress towards achieving shared goals.


Subject(s)
Global Health , Intersectoral Collaboration , Research , Sustainable Development , COVID-19/prevention & control , Developing Countries , Humans
2.
BMJ Glob Health ; 4(4): e001541, 2019.
Article in English | MEDLINE | ID: mdl-31413873

ABSTRACT

Drones are increasingly being used globally for the support of healthcare programmes. Madagascar, Malawi and Senegal are among a group of early adopters piloting the use of bi-directional transport drones for health systems in sub-Saharan Africa. This article presents the experiences as well as the strengths, weaknesses, opportunities and threats (SWOT analysis) of these country projects. Methods for addressing regulatory, feasibility, acceptability, and monitoring and evaluation issues are presented to guide future implementations. Main recommendations for governments, implementers, drone providers and funders include (1) developing more reliable technologies, (2) thorough vetting of drone providers' capabilities during the selection process, (3) using and strengthening local capacity, (4) building in-country markets and businesses to maintain drone operations locally, (5) coordinating efforts among all stakeholders under government leadership, (6) implementing and identifying funding for long-term projects beyond pilots, and (7) evaluating impacts via standardised indicators. Sharing experiences and evidence from ongoing projects is needed to advance the use of drones for healthcare.

5.
PLoS Negl Trop Dis ; 11(6): e0005658, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28614375

ABSTRACT

BACKGROUND: In order to decrease the prevalence of trachoma within the country, the Republic of South Sudan has implemented components of the SAFE strategy in various counties since 2001. Five counties in Eastern Equatoria state were surveyed in order to monitor progress of programmatic interventions and determine if additional rounds of Mass Drug Administration with azithromycin were needed. METHODOLOGY/ PRINCIPAL FINDINGS: Five counties (Budi, Lafon, Kapoeta East, Kapoeta South and Kapoeta North) were surveyed from April to October 2015. A cross-sectional, multi-stage, cluster-random sampling was used. All present, consenting residents of selected households were examined for all clinical signs of trachoma using the World Health Organization (WHO) simplified grading system. 14,462 individuals from 3,446 households were surveyed. The prevalence of trachomatous inflammation-follicular (TF) in children ages one to nine years ranged from 17.4% (95% Confidence Interval (CI): 11.4%, 25.6%) in Budi county to 47.6%, (95% CI: 42.3%, 53.0%) in Kapoeta East county. Trachomatous trichiasis (TT) was also highly prevalent in those 15 years and older, ranging between 2.6% (95% CI: 1.6%, 4.0%) in Kapoeta South to 3.9% (95% CI: 2.4%, 6.1%) in Lafon. The presence of water and sanitation were low in all five counties, including two counties which had a complete absence of latrines in all surveyed clusters. CONCLUSIONS/ SIGNIFICANCE: To our knowledge, these were the first trachoma surveys conducted in the Republic of South Sudan since their independence in 2011. The results show that despite years of interventions, four of the five surveyed counties require a minimum of five additional years of SAFE strategy implementation, with the fifth requiring at minimum three more years.


Subject(s)
Communicable Disease Control/methods , Health Services Research , Trachoma/epidemiology , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Child , Child, Preschool , Cross-Sectional Studies , Drug Therapy/methods , Female , Humans , Infant , Male , Prevalence , South Sudan/epidemiology , Trachoma/drug therapy , Trachoma/prevention & control
7.
Paediatr Perinat Epidemiol ; 27(2): 165-71, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23374061

ABSTRACT

BACKGROUND: Neonatal mortality (NM) tends to be clustered within a small subset of mothers, households and/or geographical areas. Knowledge of the maternal and newborn factors associated with NM can help identify high-risk mothers and guide the targeting of intervention programmes. METHOD: Data from pregnancy history surveys conducted as part of the Project for Advancing the Health of Newborns and Mothers (Projahnmo) in Sylhet and Mirzapur districts of Bangladesh were used to investigate risk factors for NM. We analysed data from babies born between 2001 and 2005 in the control clusters of the Projahnmo trials. Generalised linear mixed models were applied to quantify the heterogeneity among mothers and to investigate factors that contribute to this heterogeneity. RESULTS: There was an indication of correlation among siblings' outcomes. Neonates whose preceding sibling had died as a neonate in the mothers' lifetime pregnancy history were more likely (up to 1.9 times) to die than those with a living sibling. Factors that varied at the child and mother levels as well as the preceding siblings' outcome explained a large proportion (60% in Sylhet and 70% in Mirzapur) of the between-mother variation in NM. CONCLUSION: The preceding sibling's outcome may be a surrogate for genetic and other maternal health factors such as nutrition, infection or environmental factors that were not measured within Projahnmo. Further research into these factors is required in order to explain the variation in the risk for NM.


Subject(s)
Infant Mortality/trends , Maternal Welfare/statistics & numerical data , Adolescent , Adult , Bangladesh/epidemiology , Birth Intervals , Birth Order , Cluster Analysis , Female , Humans , Infant, Newborn , Male , Middle Aged , Pregnancy , Pregnancy Outcome , Randomized Controlled Trials as Topic , Risk Factors , Socioeconomic Factors , Young Adult
8.
J Immunol ; 179(4): 2445-56, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17675506

ABSTRACT

NK cells are an important source of early cytokine production in a variety of intracellular viral, bacterial, and protozoan infections; however, the role of NK cells in extracellular parasitic infections such as filarial infections is not well-defined. To investigate the role of NK cells in filarial infections, we have used an in vitro model system of culturing live infective-stage larvae (L3) or live microfilariae (Mf) of Brugia malayi, a causative agent of human lymphatic filariasis, with PBMC of normal individuals. We found that NK cells undergo early cell activation and produce IFN-gamma and TNF-alpha within 24 h after stimulation with both live L3 and Mf. Interestingly, NK cells also express IL-4 and IL-5 at this time point in response to live Mf but not L3. This is accompanied by significant alterations in NK cell expression of costimulatory molecules and natural cytotoxicity receptors. This activation is dependent on the presence of monocytes in the culture, IL-12, and direct contact with live parasites. The early activation event is subsequently followed by apoptosis of NK cells involving a caspase-dependent mechanism in response to live L3 but not live Mf. Thus, the NK cell-parasite interaction is complex, with filarial parasites inducing NK cell activation and cytokine secretion and finally NK cell apoptosis, which may provide an additional mechanism of down-regulating the host immune response.


Subject(s)
Apoptosis/immunology , Brugia malayi/immunology , Cytokines/immunology , Filariasis/immunology , Killer Cells, Natural/immunology , Lymphocyte Activation/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Wuchereria bancrofti/immunology , Animals , Cytokines/metabolism , Down-Regulation/immunology , Filariasis/metabolism , Filariasis/parasitology , Host-Parasite Interactions/immunology , Humans , Killer Cells, Natural/metabolism , Killer Cells, Natural/parasitology , Larva/immunology , Models, Immunological , Th1 Cells/metabolism , Th1 Cells/parasitology , Th2 Cells/metabolism , Th2 Cells/parasitology
9.
J Immunol ; 176(7): 3885-9, 2006 Apr 01.
Article in English | MEDLINE | ID: mdl-16547219

ABSTRACT

Patent lymphatic filariasis is characterized by profound Ag-specific T cell hyporesponsiveness with impaired IFN-gamma and IL-2 production. Because T cells have been shown to express a number of TLR and to respond to TLR ligands, we hypothesized that diminished T cell TLR function could partially account for the T cell hyporesponsiveness in filariasis. T cells expressed TLR1, TLR2, TLR4, and TLR9, and the baseline expression of TLR1, TLR2, and TLR4, but not TLR9 was significantly lower in T cells of the filarial-infected individuals compared with the uninfected individuals (both endemic and nonendemic). TLR function was significantly diminished in the T cells of filarial-infected individuals based on decreased T cell activation/cytokine production in response to TLR ligands. Thus, diminished expression and function of T cell TLR is a novel mechanism underlying T cell immune tolerance in lymphatic filariasis.


Subject(s)
Filariasis/immunology , Filariasis/metabolism , Filarioidea/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Toll-Like Receptors/immunology , Toll-Like Receptors/metabolism , Animals , Cell Separation , Filariasis/parasitology , Gene Expression Regulation , Humans , Interferons/metabolism , Ligands
10.
J Immunol ; 176(5): 3248-56, 2006 Mar 01.
Article in English | MEDLINE | ID: mdl-16493086

ABSTRACT

Patent lymphatic filariasis is characterized by a profound down-regulation of immune responses with both parasite Ag-specific tolerance and bystander suppression. Although this down-regulation is confined to the Th1 arm of the immune system in response to parasite Ag, we hypothesized a more generalized suppression in response to live parasites. Indeed, when we examined the cytokine profile of a cohort of filaria-infected (n = 10) and uninfected (n = 10) individuals in response to live infective-stage larvae or microfilariae of Brugia malayi, we found significant impairment of both Th1 and Th2 cytokines characterized by diminished production of IFN-gamma, TNF-alpha, IL-4, IL-5, and IL-10 in infected patients. The molecular basis of this impaired Th1/Th2 response was examined, and we identified three major networks of immunoregulation and tolerance. First, impaired induction of T-bet and GATA-3 mRNA underlies the Th1/Th2 deficiency in infected individuals. Second, regulatory networks, as evidenced by significantly increased expression of Foxp3 (natural regulatory T cell marker) and regulatory effectors such as TGF-beta, CTLA-4, PD-1, ICOS, and indoleamine 2,3-dioxygenase play an important role in immunosuppression. Third, the compromise of effector T cell function is mediated by the enhanced induction of anergy-inducing factors cbl-b, c-cbl (cbl is abbreviation for Casitas B lymphoma), Itch, and Nedd4. Indeed, blocking CTLA-4 or neutralizing TGF-beta restored the ability to mount Th1/Th2 responses to live parasites and reversed the induction of anergy-inducing factors. Hence, we conclude that a profound impairment of live parasite-specific Th1 and Th2 immune responses occurs in lymphatic filariasis that is governed at the transcriptional level by a complex interplay of inhibitory mediators.


Subject(s)
Brugia malayi/growth & development , Brugia malayi/immunology , Elephantiasis, Filarial/immunology , Elephantiasis, Filarial/parasitology , Th1 Cells/immunology , Th2 Cells/immunology , Animals , Antibodies, Blocking/pharmacology , Antigens, CD , Antigens, Differentiation/immunology , Antigens, Differentiation/metabolism , CTLA-4 Antigen , Cells, Cultured , Cytokines/biosynthesis , Down-Regulation/immunology , Forkhead Transcription Factors/biosynthesis , Forkhead Transcription Factors/genetics , GATA3 Transcription Factor/antagonists & inhibitors , Host-Parasite Interactions/immunology , Humans , Immune Tolerance/genetics , Signal Transduction/genetics , Signal Transduction/immunology , Suppressor of Cytokine Signaling Proteins/biosynthesis , Suppressor of Cytokine Signaling Proteins/genetics , T-Box Domain Proteins , Th1 Cells/metabolism , Th1 Cells/parasitology , Th2 Cells/metabolism , Th2 Cells/parasitology , Transcription Factors/antagonists & inhibitors , Transforming Growth Factor beta/biosynthesis , Transforming Growth Factor beta/genetics , Ubiquitin-Protein Ligases/antagonists & inhibitors
11.
J Immunol ; 175(2): 1170-6, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-16002719

ABSTRACT

Lymphatic filariasis is a disease characterized by immune dysregulation involving APC and T cell populations. To assess the contribution of TLR in mediating this dysregulation, we examined the expression of TLR1, TLR2, TLR4, and TLR9 on B cells and monocytes of filaria-infected and uninfected individuals. Baseline expression of TLR was significantly lower in B cells but not in monocytes of the filaria-infected group compared with the uninfected group. Upon stimulation with filarial Ag, a diminished up-regulation of TLR was observed in both B cells and monocytes of infected individuals. Finally, stimulation of B cells and monocytes with TLR ligands resulted in decreased B cell and monocyte activation/cytokine production, indicating a state of immune tolerance. This dysregulation is associated with diminished CD4(+) T cell production of IFN-gamma and IL-5. The diminished expression and function of TLR is thus a likely consequence of chronic Ag stimulation and could serve as a novel mechanism underlying the dysfunctional immune response in filariasis.


Subject(s)
Elephantiasis, Filarial/immunology , Elephantiasis, Filarial/metabolism , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/biosynthesis , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Cell Surface/biosynthesis , Adult , Animals , Antigens, Helminth/pharmacology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , B-Lymphocytes/parasitology , Brugia malayi/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/parasitology , Cells, Cultured , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/metabolism , Elephantiasis, Filarial/parasitology , Female , Humans , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/biosynthesis , Interleukin-5/antagonists & inhibitors , Interleukin-5/biosynthesis , Lymphocyte Activation/immunology , Male , Membrane Glycoproteins/metabolism , Membrane Glycoproteins/physiology , Middle Aged , Monocytes/immunology , Monocytes/metabolism , Monocytes/parasitology , Receptors, Cell Surface/metabolism , Receptors, Cell Surface/physiology , Toll-Like Receptor 1 , Toll-Like Receptor 2 , Toll-Like Receptor 4 , Toll-Like Receptor 9 , Toll-Like Receptors , Tuberculin/pharmacology , Wuchereria bancrofti/immunology
12.
J Infect Dis ; 191(6): 1018-26, 2005 Mar 15.
Article in English | MEDLINE | ID: mdl-15717282

ABSTRACT

We examined the expression of chemokine receptors on the surfaces of T cells and B cells from 27 individuals either with lymphatic filarial disease (lymphedema), with the asymptomatic or subclinical form of filarial infection, or without filarial infection. Individuals with lymphedema exhibited increased percentages of CCR9-expressing T cells and CCR9-expressing B cells and decreased percentages of both CXCR1-and-CXCR3-expressing T cells and CXCR1-and-CXCR3-expressing B cells, compared with asymptomatic or uninfected individuals. A significant correlation was found between the grade of lymphedema and the percentage of CCR9-expressing T cells and CCR9-expressing B cells. The percentages of CCR9-expressing T cells and CCR9-expressing B cells from patients with lymphedema was significantly up-regulated in response to live, infective-stage larvae of Brugia malayi but not to microfilariae of this parasite. Finally, individuals with lymphedema had significantly higher concentrations of interleukin-8, macrophage inflammatory protein (MIP)-1alpha , MIP-1beta , monocyte chemotactic protein 1, thymus-and-activation-regulated chemokine, and interferon-inducible protein 10 in their serum than did uninfected individuals. These results suggest that chemokine receptors (particularly CCR9) are involved in the pathogenesis of lymphatic filarial disease and that trafficking of particular cellular subsets may influence clinical outcome.


Subject(s)
B-Lymphocytes/metabolism , Brugia malayi/pathogenicity , Lymphedema/physiopathology , Receptors, Chemokine/metabolism , T-Lymphocytes/metabolism , Adult , Animals , B-Lymphocytes/classification , Brugia malayi/growth & development , Brugia malayi/immunology , Chemokines/metabolism , Chronic Disease , Elephantiasis, Filarial/parasitology , Elephantiasis, Filarial/physiopathology , Female , Humans , Larva/immunology , Larva/pathogenicity , Lymphedema/parasitology , Male , Middle Aged , Phenotype , Receptors, CCR , T-Lymphocytes/classification , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...